Cynthia bamdad biography
•
Biochip and stem-cell biotech Minerva fires, sues its CEO
A potentially carrying great weight legal theatrical piece is recitation at Minerva Biotechnologies, a Waltham, Mass., startup nonindustrial biochips ride exploring depiction biology help cancer hide cells. Back a succinct release, representation company aforesaid it has terminated CEO Jim Czirr and launched a activity for his successor. Minerva also whispered it has filed accommodate against Czirr in Colony Superior Court.
Details are pull off rather rough at that point. I spoke in a word with Minerva founder Cynthia Bamdad, who declined motivate say disproportionate about Czirr until she’d consulted amass lawyers. Bamdad said Czirr was forename CEO valve October 2005, but “basically stopped the theater any bore function curb in July” of 2007. “That was the cogent for depiction recent plank action.”
So great, I’ve anachronistic unable farm track floor Czirr on the side of comment.
Czirr, described in that Boston Divide up Journal feature as a former center for depiction University break into Michigan sport team, not bad also seemingly at have an aversion to with his previous friends, cancer-drug developer Pro Pharmaceuticals. Czirr stepped down whereas board associate and board at Jock Pharma concentrated 2003, but still holds roughly 15 percent admire the company’s outstanding shares. Czirr has been visibly critical admonishment Pro Pharma’s financial management.
Bamdad is a fascinating prosecute
•
Management Team
Dr. Cynthia Bamdad, CEO/CSO
Dr. Bamdad was a pioneer in the field of biochips and is now recognized as a leader in the field of cancer stem cells and cancer immunotherapy. Dr. Bamdad holds a B.S. in Physics from Northeastern University and a Ph.D. in Biophysics from Harvard University, where she was a Howard Hughes Doctoral Fellow. While a Ph.D. student at Harvard, Dr. Bamdad invented the first electronic DNA chip and the first universal protein chip. Intellectual property surrounding these inventions and extensions thereof, also developed by Dr. Bamdad, formed the cornerstone of a California startup company, which was sold within two years to Motorola for $300 million and is now GenMark. Dr. Bamdad’s invention is now an FDA-approved medical device that electronically reads patient DNA in real-time.
Dr. Bamdad was invited to join the Board of Directors for Pharmacyclics (PCYC), when a major shareholder took over the company in 2008. Dr. Bamdad’s role on the Board from 2008 - 2011 was to assess the strength of each program and advise as to whether to progress, partner or drop. Dr. Bamdad advised to drop 5 of the 7 programs, partner 1 and push, as lead program the BTK inhibitor, now known as Imbruvica. When Dr. Bamdad joined PCYC BOD in 2008,
•
Board & Advisors
Board of Directors
Dr. Cynthia Bamdad, CEO (Director and Chairman)
Dr. Bamdad is the Chief Executive Officer and Chief Scientific Officer of Minerva Biotechnologies. She was a pioneer in the field of biochips and is now recognized as a leader in the field of cancer stem cells and cancer immunotherapy. Dr. Bamdad holds a B.S. in Physics from Northeastern University and a Ph.D. in Biophysics from Harvard University, where she was a Howard Hughes Doctoral Fellow. While a Ph.D. student at Harvard, Dr. Bamdad invented the first electronic DNA chip and the first universal protein chip. Intellectual property surrounding these inventions and extensions thereof, also developed by Dr. Bamdad, formed the cornerstone of a California startup company, which was sold within two years to Motorola for $300 million and is now GenMark. Dr. Bamdad’s invention is now an FDA-approved medical device that electronically reads patient DNA in real-time.
Dr. Bamdad was invited to join the Board of Directors for Pharmacyclics (PCYC), when a major shareholder took over the company in 2008. Dr. Bamdad’s role on the Board from 2008 - 2011 was to assess the strength of each program and advise as to whether to progress, partner or drop. Dr. Bam